Skip to Main Content
Transmittal #
R39OTN
Subject
Change in Coding on Medicare Claims for Darbepoetin Alfa (trade name Aranesp) and Epoetin Alfa (trade name Epogen, EPO) For Treatment Of Anemia In End Stage Renal Disease (ESRD) Patients On Dialysis
Implementation Date
01/05/2004
CR #
2963
Publication #
100-20
MM Article #
MM2963
MM Article Release Date
02/13/2004
MM Article Revised Date
N/A
Related CR Release Date
10/31/2004
Related CR Effective Date
01/01/2004
Job Aid #
N/A